UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000002505 |
|---|---|
| Receipt number | R000003071 |
| Scientific Title | Radiofrequency ablation for large liver cancers using a switchin controller |
| Date of disclosure of the study information | 2009/09/16 |
| Last modified on | 2019/03/29 15:54:51 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Radiofrequency ablation for large liver cancers using a switchin controller
Acronym
RFA for large liver cancers using a switchin controller
Scientific Title
Radiofrequency ablation for large liver cancers using a switchin controller
Scientific Title:Acronym
RFA for large liver cancers using a switchin controller
Region
| Japan |
Condition
Condition
Liver cancer
Classification by specialty
| Hepato-biliary-pancreatic medicine | Hepato-biliary-pancreatic surgery | Radiology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
Safety
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Complication after liver radiofrequency
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Device,equipment | Maneuver |
Interventions/Control_1
12-months enrollment. 12-month follow-up.
Number of subjects: 20.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
1. Patients with liver cacer diagnosed by biopsy or combination of radiographic findings and tumor markers.
2. The maximum tumor size of 3-10 cm with a tumor number of 3 or less.
3. Child-Pugh grade A liver profile.
4. Not a surgical candidate.
5. Afe of 20 years or more.
6. PS of 1 or 1.
7. Life-expectancy of 2 months or longer.
8. Informed consent from the patient.
Key exclusion criteria
1. Abnormal coagulability.
a) platelet count of 50000/mm3 or less.
b) INR larger than 1.5.
2. Vascular and biliary invasion.
3. Extrahepatic metastasis.
Target sample size
20
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Atsuhiro Nakatsuka |
Organization
Mie University Hospital
Division name
Interventional Radiology
Zip code
Address
2-174 Edobashi, Tsu Mie, 514-8507, Japan
TEL
059-231-5029
nkatuka@clin.medic.mie-u.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Atsuhiro Nakatsuka |
Organization
Mie University Hospital
Division name
Interventional Radiology
Zip code
Address
2-174 Edobashi, Tsu Mie, 514-8507, Japan
TEL
059-231-5029
Homepage URL
nakatuka@clin.medic.mie-u.ac.jp
Sponsor or person
Institute
Department of Interventional Radiology, Mie University Hospital
Institute
Department
Personal name
Funding Source
Organization
Department of Interventional Radiology, Mie University Hospital
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2009 | Year | 09 | Month | 16 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2009 | Year | 09 | Month | 16 | Day |
Date of IRB
| 2009 | Year | 08 | Month | 31 | Day |
Anticipated trial start date
| 2009 | Year | 09 | Month | 01 | Day |
Last follow-up date
| 2014 | Year | 04 | Month | 30 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2009 | Year | 09 | Month | 16 | Day |
Last modified on
| 2019 | Year | 03 | Month | 29 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003071
